| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |